Research Topics
Genomes and GenesSpecies | A L AndreuSummaryAffiliation: Hospital Universitari Vall d'Hebron Country: Spain Publications
| Collaborators
|
Detail Information
Publications
McArdle disease: molecular genetic updateA L Andreu
Dept Patologia Mitocondrial i Neuromuscular, Centre d Investigacions en Bioquimica i Biologia Molecular CIBBIM, Institut de Recerca Vall d Hebron, Barcelona, Spain
Acta Myol 26:53-7. 2007..Molecular heterogeneity has been demonstrated by the identification to date of more than 65 mutations in the PYGM gene...
Autosomal dominant limb-girdle muscular dystrophy: a large kindred with evidence for anticipationJ Gamez
Department of Neurology, Hospital Vall d Hebron, Barcelona, Spain
Neurology 56:450-4. 2001..Fourteen genetically distinct forms of limb-girdle muscular dystrophy (LGMD) have been identified, including five types of autosomal dominant LGMD (AD-LGMD)...
Exercise intolerance resulting from a muscle-restricted mutation in the mitochondrial tRNA(Leu (CUN)) geneC Vives-Bauza
Research Centre for Biochemistry and Molecular Biology, Universitary Hospital Vall d'Hebron, Barcelona, Spain
Ann Med 33:493-6. 2001..CONCLUSION: Mutations in any mitochondrial gene should be considered in the differential diagnosis of patients with lifelong exercise intolerance, even when the neurological examination is normal...
A novel autosomal dominant limb-girdle muscular dystrophy (LGMD 1F) maps to 7q32.1-32.2L Palenzuela
Centre d Investigacions en Bioquimica i Biologia Molecular CIBBIM, Hospital Universitari Vall d Hebron, Barcelona, Spain
Neurology 61:404-6. 2003..1-32.2. Within this chromosomal region, filamin C, a gene encoding actin binding protein highly expressed in muscle, was an obvious candidate gene; however, the authors did not detect any defects in filamin C or its protein product...
Splicing mosaic of the myophosphorylase gene due to a silent mutation in McArdle diseaseI Fernandez-Cadenas
, Hospital Universitari Vall d'Hebron, Barcelona, Spain
Neurology 61:1432-4. 2003..These findings suggest that, in patients with McArdle disease in whom no pathogenic mutation has been found, any a priori silent polymorphism should be re-evaluated as a putative splicing mutation...
Molecular genetics of McArdle's diseaseG Nogales Gadea
Dept Patologia Mitocondrial i Neuromuscular, Centre d Investigacions en Bioguimica y Bioloqía Molecular, Institut de Recera Vall d Hebron, Barcelona, Spain
Curr Neurol Neurosci Rep 7:84-92. 2007..There is not a specific treatment for McArdle's disease, but some nutritional treatments in combination with aerobic conditioning could improve the quality of life in most patients...
Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIEJ Torres-Torronteras
Laboratori of Neuromuscular and Mitochondrial Disorders, Institut de Recerca Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
Gene Ther 18:795-806. 2011..Our results suggest that hematopoietic gene therapy could be an alternative treatment for this devastating disorder in the future...
[Mitochondrial disorders: a classification for the 21st century]A L Andreu
Centro de Investigaciones en Bioquimica y Biologia Molecular, Hospital Vall d Hebron, Barcelona, Spain
Neurologia 19:15-22. 2004..Alterations in those genes may be point mutations, deletions or duplications in the mitochondrial DNA and alterations of the genomic signaling between nucleus and mitochondria...
Genotype-phenotype correlation in the 5703G>A mutation in the tRNA(ASN) gene of mitochondrial DNAC Vives-Bauza
Centre d'Investigacions en Bioquimica i Biologia Molecular, Hospital Universitari Vall d'Hebron, Barcelona, Spain
J Inherit Metab Dis 26:507-8. 2003..We report a second patient with the same mutation and phenotype...
Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patientsM Crespo
Infectious Diseases Department, Hospital Universitari Vall d Hebron, Barcelona, Spain
J Viral Hepat 14:228-38. 2007..Frequent monitoring of virological response may be very helpful to optimize treatment compliance, to tailor treatment duration and to minimize side effects...
Phenotypic variability in a Spanish family with MNGIEJ Gamez
Department of Neurology, Hospital Gral, Vall d Hebron, Barcelona, Spain
Neurology 59:455-7. 2002..The first thymidine phosphorylase mutation identified in Spain showed phenotypic variability at onset...
Reduced mitochondrial DNA transcription in senescent rat heartA L Andreu
Centre d Investigacions en Bioquímica i Biologia Molecular dels Hospitals Vall d Hebrón, P Vall d Hebrón 119 125, Barcelona, E 08035, Spain
Biochem Biophys Res Commun 252:577-81. 1998..This reduction in the mtDNA transcriptional rate in the heart of senescent animals suggests that this could be one of the molecular bases underlying senescence of the myocardium...
A new mutation in the regulatory domain of the myophosphorylase gene affecting protein dimer contactJ Gamez
Department of Neurology, Hospitals Vall d Hebron, Barcelona, Spain
Muscle Nerve 22:1136-8. 1999..These data further emphasize the importance of private mutations in McArdle's disease, some of which are associated with specific ethnic groups...
Mitochondrial DNA oxidation and manganese superoxide dismutase activity in peripheral blood mononuclear cells from type 2 diabetic patientsM Garcia-Ramirez
CIBERDEM ISCIII and Diabetes Research Unit, Institut de Recerca, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain
Diabetes Metab 34:117-24. 2008..To investigate the balance between parameters of oxidative stress and antioxidant defences in the mitochondria of peripheral blood mononuclear cells (PBMCs) of type 2 diabetic patients with late complications...
Familial expansile osteolysis in a large Spanish kindred resulting from an insertion mutation in the TNFRSF11A geneL Palenzuela
, Hospital Universitari Vall d'Hebron, Barcelona, Spain
J Med Genet 39:E67. 2002
[Mitochondrial encephalopathies: where are we going?]S DiMauro
H Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, New York, NY, USA
Rev Neurol 28:164-8. 1999..The molecular base of nDNA mutations; 3. The coenzyme Q10 deficiency; 4. Defects of translocases; 5. Defects of mitochondrial protein importation, and 6. Defects of intergemonic signalling...
A new mutation in the myophosphorylase gene (Asn684Tyr) in a Spanish patient with McArdle's diseaseA L Andreu
H Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, Department of Neurology, College of Physicians and Surgeons, New York, NY 10032, USA
Neuromuscul Disord 9:171-3. 1999....
Variable presentation of the clinical phenotype of McArdle's disease in a kindred harbouring a novel compound genotype in the muscle glycogen phosphorylase geneC Paradas
Unidad de Neurologia, Hospital de Zafra, Badajoz, Spain
Neurosci Lett 391:28-31. 2005..Our results indicate no association of the I/D ACE trait in this family, suggesting that other factors would be more relevant in determining the severity of the clinical presentation...
A mitochondrial DNA duplication as a marker of skeletal muscle specific mutations in the mitochondrial genomeM Mancuso
J Med Genet 41:e73. 2004
A novel missense mutation (W797R) in the myophosphorylase gene in Spanish patients with McArdle diseaseR Fernandez
H Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
Arch Neurol 57:217-9. 2000..To investigate the degree of genetic heterogeneity of myophosphorylase deficiency (McArdle disease) in Spain through molecular studies of 10 new patients...
Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation studyM A Martin
Centro de Investigación y Sección de Neuropatología, Hospital Universitario 12 de Octubre, Madrid, Spain
Ann Neurol 50:574-81. 2001..The mutations of charged residues would be expected to interfere with internal hydrogen bonding networks, introducing severe incompatible partnering that is caused by poor packing or electrostatic repulsions...
Myophosphorylase deficiency (glycogenosis type V; McArdle disease)S Dimaur
Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
Curr Mol Med 2:189-96. 2002..Mutations are spread throughout the gene and there is no clear genotype:phenotype correlation. High-protein diet and aerobic exercise are beneficial, and gene therapy appears promising...
McArdle disease: another systemic low-inflammation disorder?Alejandro Lucia
Universidad Europea de Madrid, 28670 Madrid, Spain
Neurosci Lett 431:106-11. 2008..Our results support the rationale for prescribing carefully supervised exercise training in these patients...
[Private mutations in the myophosphorylase gene: the first case in a patient of Latin American descent]I Fernandez Cadenas
Universidad de Zaragoza, 50013 Zaragoza, Espana
Rev Neurol 45:280-3. 2007..McArdle's disease (glycogenoses type V) is a common metabolic myopathy caused by deficient myophosphorylase activity. The disease is due to mutations in the myophosphorylase (PYGM) gene and is present in a large number of countries...
AMPD1 genotypes and exercise capacity in McArdle patientsJ C Rubio
Centro de Investigacion, Hospital Universitario 12 de Octubre, Madrid, Spain
Int J Sports Med 29:331-5. 2008....
Mutations in mitochondrial DNA as a cause of exercise intoleranceS DiMauro
Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA
Ann Med 33:472-6. 2001..Contrary to the general rules of mitochondrial genetics, all patients were sporadic cases and all mutations were restricted to skeletal muscle, suggesting that they were somatic mutations not affecting the germ line...
Reversion of mtDNA depletion in a patient with TK2 deficiencyM R Vila
Department of Neurology, Columbia University College of Physicians and Surgeons New York, NY, USA
Neurology 60:1203-5. 2003..This report extends the phenotypic expression of primary TK2 deficiency and suggests that factors other than TK2 may modify expression of the clinical phenotype in patients with MDS syndrome...
Can patients with McArdle's disease run?M Perez
Universidad Europea de Madrid, Madrid, Spain
Br J Sports Med 41:53-4. 2007..These preliminary data suggest the potential therapeutic value of this type of exercise in these patients...
Infusion of platelets transiently reduces nucleoside overload in MNGIEM C Lara
Laboratori de Patologia Neuromuscular i Mitocondrial, Institut de Recerca Hospital Universitari Vall d'Hebron, Pg. Vall d'Hebron 119, 08035 Barcelona, Spain
Neurology 67:1461-3. 2006....
Exercise capacity in a 78 year old patient with McArdle's disease: it is never too late to start exercisingM Perez
Universidad Europea de Madrid, Madrid, Spain
Br J Sports Med 40:725-6; discussion 726. 2006..The data suggest that, with pre-exercise sucrose administration, such patients may be candidates for systematic reconditioning, which may improve functional capacity and quality of life...
Increased muscle nucleoside levels associated with a novel frameshift mutation in the thymidine phosphorylase gene in a Spanish patient with MNGIEA Blazquez
Centro de Investigación and Sección de Neuropatología, Hospital Universitario 12 de Octubre, Madrid, Spain
Neuromuscul Disord 15:775-8. 2005..1460_1479delGACGGCCCCGCGCTCAGCGG, resulting in a frameshift and synthesis of a protein larger than the wild-type. Thymidine and deoxyuridine accumulation was detected in muscle, indicating loss-of-function of thymidine phosphorylase (TP)...
Characterisation of repeat and palindrome elements in patients harbouring single deletions of mitochondrial DNAA Solano
, Universidad de Zaragoza, Zaragoza, Spain
J Med Genet 40:e86. 2003
Diseases of oxidative phosphorylation due to mtDNA mutationsS DiMauro
Department of Neurology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
Semin Neurol 21:251-60. 2001....
A new mtDNA mutation in the tRNA(Leu(UUR)) gene associated with ocular myopathyY Campos
, Hospital 12 de Octubre, , 28041, Madrid, Spain
Neuromuscul Disord 11:477-80. 2001..The T3273C mutation affects a strictly conserved base pair in the anticodon stem and was not found in controls, thus satisfying the accepted criteria for pathogenicity...
Manifesting heterozygotes in a Japanese family with a novel mutation in the muscle-specific phosphoglycerate mutase (PGAM-M) geneG M Hadjigeorgiou
Department of Neurology, H Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
Neuromuscul Disord 9:399-402. 1999..Two heterozygous family members for the G97D mutation presented with exercise intolerance and muscle cramps. We describe the first PGAM-M mutation in the Japanese population and confirm that heterozygous individuals can be symptomatic...
